Cervical dystonia ( spasmodictorticollis) is a focal dystonia of the cervical region.
2
We describe a case of cervical myelopathy in a patient with PD, multiple fractures involving the atlas and axis vertebrae, and spasmodictorticollis.
3
To determine whether an association exists between the side of degenerative changes and type of spasmodictorticollis a chi(2) test was used.
Uso de cervical dystonia em inglês
1
Primary cervicaldystonia patients produced less action verbs compared to healthy controls.
2
Action language, however, has not been investigated in primary cervicaldystonia, a hyperkinetic movement disorder.
3
Further, cervicaldystonia can occur as a feature of segmental or generalized dystonias and cerebral palsy.
4
Interpretation: Pallidal neurostimulation for 3 months is more effective than sham stimulation at reducing symptoms of cervicaldystonia.
5
However, pharmacoeconomic studies evaluating treatment and disease costs have not taken into consideration the long-term complications of cervicaldystonia.
6
Results: Dysphagia was suspected in 36% of patients with cervicaldystonia on the basis of clinical assessment.
7
Thirty patients with Parkinson's disease, thirty primary cervicaldystonia patients and thirty healthy controls were included in the study.
8
The suit, which was filed in December, relates to Elan's Myobloc product and its use in the treatment of cervicaldystonia.
9
Complications of cervicaldystonia need to be taken into consideration when weighting risks and calculating costs of the disease and its treatment.
10
Success with this study would significantly impact the clinical care delivery for patients with cervicaldystonia, as well as widening potential access to effective treatment.
11
Athlone-based pharmaceutical firm Elan Corp has announced that two clinical studies of Neurobloc, a drug it is developing to treat cervicaldystonia, have been successful.
12
Method: Electrophysiological methods related to oropharyngeal swallowing were used to investigate 25 patients with cervicaldystonia and 25 age matched normal volunteers.
13
Conclusion: Botulinum toxin type B (NeuroBloc) is safe and efficacious at 5,000 U and 10,000 U for the management of patients with cervicaldystonia.
14
Background: Cervicaldystonia is managed mainly by repeated botulinum toxin injections.
15
Cervicaldystonia (spasmodic torticollis) is a focal dystonia of the cervical region.
16
Cervicaldystonia is the most frequent form of focal dystonia.